Skip to content
healthcare.dev

Fulvestrant

NDC 63323-715, Fulvestrant, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-715
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA210326
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-715 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FULVESTRANT50 mg/mL

Pharmacologic classes

Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]

Package NDCNDC-11Package
63323-715-05633230715052 SYRINGE, GLASS in 1 CARTON (63323-715-05) / 5 mL in 1 SYRINGE, GLASS (63323-715-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fabe9bd8-ac23-4df1-a89a-223d5cd38914
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63323-715

Use it

Look up 63323-715 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-715 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-715. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.